Related Experiment Video
Updated: Jul 18, 2026
07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas
Delphine Maucort-Boulch1, Malika Djeridane, Pascal Roy
1Service de Biostatistique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon et Laboratoire Biostatistique Sante, equipe UMR CNRS 5558, Lyon, France.
Cancer
|December 13, 2006
Summary
A new prognostic scoring system (PSS) for Hodgkin lymphoma (HL) accurately predicts patient survival. This system offers a valuable alternative for assessing prognosis in HL patients, improving upon existing methods.
Area of Science:
- Hematology
- Oncology
- Medical Statistics
Background:
- Hodgkin lymphoma (HL) prognosis assessment has relied on various prognostic systems derived from the Ann Arbor classification since 1980.
- A need exists for refined prognostic tools to better stratify HL patients.
Purpose of the Study:
- To develop and validate a novel 3-stage prognostic scoring system (PSS) for Hodgkin lymphoma.
- To compare the efficacy of the PSS against existing prognostic systems.
Main Methods:
- Utilized modern statistical methods on data from 955 HL patients treated between 1981 and 1996.
- Assigned values to variables predicting 10-year overall survival (10-year OS) to create a 3-stage scoring system.
- Compared 10-year OS, 5-year event-free survival (5-year EFS), and 5-year freedom from progression (5-year FFP) rates of the PSS with other systems.
Main Results:
- Identified four key predictors of 10-year OS: age, number of involved lymphoid areas, visceral disease, and systemic symptoms.
- The PSS demonstrated superior discrimination and prediction abilities compared to existing systems.
- The PSS accurately stratified patients into distinct prognostic groups with varying survival rates and was validated in a subsequent cohort.
Conclusions:
- The developed prognostic scoring system (PSS) is a valuable and effective tool for evaluating Hodgkin lymphoma patients.
- PSS provides a reliable alternative to current prognostic systems, enhancing the ability to predict patient outcomes.